Medullo in the Mountains: The key researchers and clinicians in the medulloblastoma field gathered annually for a great networking opportunity to share unpublished data, experience and insights into how we can develop more effective therapies for children with Medulloblastoma tumours.
The COG, with more than 10,000 experts worldwide, has nearly 100 active clinical-translational trials open at any given time. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship.
Topics of discussion have ranged from the mechanisms of metastasis and the structure of the blood brain barrier to strategies for immunotherapy (CAR-T cells and RNA vaccines) to the safety and ethics of research biopsies. Going forward we (PNOC) will continue our discussions of topics of interest, with future sessions planned on drug delivery as well as on late effects and complications of therapy.
Curemedullo Is A Division Of The Carson Leslie Foundation ©2021 All rights reserved. The Carson Leslie Foundation (CLF) is a registered 501(c)(3) charity organization. Please note that cureMEdullo provides this information for the benefit of the medulloblastoma and childhood cancer community. cureMEdullo and CLF are not medical providers or a health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.